Best World to invest in A*Star startup with an eye on stem cell-based products
Nisha Ramchandani
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
BEST World International is investing in A*Star spinoff Celligenics as it seeks to leverage on synergies with its own business in the health and wellness sector.
In a filing with the Singapore Exchange on Monday, it said that it had entered into a share subscription agreement (SSA) with Celligenics.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result